share_log

Chardan Capital Maintains Buy on Metagenomi, Maintains $21 Price Target

Moomoo 24/7 ·  Mar 28 08:23

Chardan Capital analyst Geulah Livshits maintains Metagenomi (NASDAQ:MGX) with a Buy and maintains $21 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment